Surzebiclimab
Clivatuzumab
Sontuzumab
Gatipotuzumab
Minretumomab
Ensituximab
MUC1, mucin core
MUC5AC motif peptide
Gefarnate
Guaifenesin
Ac5GalNTGc epimer
Ac5GalNTGc
Eudragit RS 100
Tasuldine